Achilles Therapeutics plc (ACHL) Ownership

2.49 ↓0.06 (-2.35%)
As of May 23, 2022, 9:45am EST.

Institutional Ownership

RA Capital Management, LLC is the biggest individual institutional holder of Achilles Therapeutics plc (ACHL), owning a total of 5 million shares. Combined, the top 86 institutional holders of ACHL own 181.09% of the company with a total of 72.9 million shares.

In the latest ownership report, the top 86 institutional holders have increased their combined ownership of ACHL by 19.3 million shares, a 20.94% increase from the quarter prior.

Institution Ownership Chart

Your browser does not support this chart.

Top Institutions

OwnerPercent OwnedPercent ChangeShares OwnedShare ChangeDate Reported
RA Capital Management, LLC12.862%0.000%5,014,68702021-12-31
RA Capital Management, LLC12.350%0.000%5,014,68702021-09-30
RA Capital Management, LLC12.350%261.058%5,014,6873,625,7992021-06-30
Baker Bros Advisors LP6.647%0.000%2,591,36602021-12-31
Baker Bros Advisors LP6.382%0.000%2,591,36602021-09-30
Baker Bros Advisors LP6.382%0.000%2,591,36602021-06-30
Baker Bros Advisors LP6.379%0.000%2,591,3662,591,3662021-03-31
Baker Bros Advisors LP6.359%0.000%2,591,36602022-03-31
Artal Group S A5.785%0.000%2,255,37502021-12-31
Artal Group S A5.555%0.000%2,255,37502021-09-30
Artal Group S A5.555%0.000%2,255,37502021-06-30
Artal Group S A5.552%0.000%2,255,3752,255,3752021-03-31
Redmile Group, LLC5.356%0.000%2,088,08902021-12-31
Redmile Group, LLC5.143%0.000%2,088,08902021-06-30
Redmile Group, LLC5.143%0.000%2,088,08902021-09-30
Redmile Group, LLC5.140%0.000%2,088,0892,088,0892021-03-31
Orbimed Advisors, LLC4.065%0.000%1,584,84502021-12-31
Orbimed Advisors, LLC3.903%0.000%1,584,84502021-06-30
Orbimed Advisors, LLC3.903%0.000%1,584,84502021-09-30
Orbimed Advisors, LLC3.902%0.000%1,584,8451,584,8452021-03-31
Boxer Capital LLC3.783%0.000%1,536,01602021-09-30
Boxer Capital LLC3.783%-0.013%1,536,016-1922021-06-30
Boxer Capital LLC3.782%0.000%1,536,2081,536,2082021-03-31
Perceptive Advisors LLC3.719%0.000%1,510,7501,510,7502021-03-31
RA Capital Management, LLC3.419%0.000%1,388,8881,388,8882021-03-31
Point72 Asset Management, L.P.2.565%100.000%1,000,000500,0002021-12-31
Farallon Capital Management, L.L.C.2.462%0.000%1,000,0001,000,0002021-03-31
Farallon Capital Management, L.L.C.2.454%-0.346%996,540-3,4602021-06-30
Deerfield Management Co1.969%0.000%800,000800,0002021-03-31
Perceptive Advisors LLC1.938%0.000%755,37502021-12-31
Perceptive Advisors LLC1.860%-50.000%755,375-755,3752021-09-30
Perceptive Advisors LLC1.860%0.000%755,37502021-06-30
JPMorgan Chase & Co1.540%0.000%625,750625,7502021-03-31
Bank of America Corp1.418%0.000%576,085576,0852021-03-31
Point72 Asset Management, L.P.1.231%0.000%500,000500,0002021-09-30
Farallon Capital Management, L.L.C.1.108%-54.844%450,000-546,5402021-09-30
Woodline Partners LP0.832%0.000%324,387324,3872021-12-31
Peregrine Capital Management LLC0.793%0.000%322,261322,2612021-03-31
Deerfield Management Co0.742%-62.321%301,431-498,5692021-06-30
Sphera Funds Management Ltd.0.739%0.000%300,000300,0002021-03-31
AXA SA0.725%1.206%282,8233,3692021-12-31
Sphera Funds Management Ltd.0.720%-2.602%292,194-7,8062021-06-30
AXA SA0.688%-48.083%279,454-258,8162021-09-30
AXA SA0.663%0.000%269,135269,1352021-06-30
Sphera Funds Management Ltd.0.622%-17.007%242,500-49,6942021-09-30
Woodline Partners LP0.588%0.000%238,822238,8222021-03-31
Peregrine Capital Management0.556%-29.973%225,669-96,5922021-06-30
Peregrine Capital Management LLC0.556%-29.973%225,669-96,5922021-06-30
BlackRock Inc0.545%0.000%212,432212,4322021-12-31
Millennium Management LLC0.499%0.000%202,785202,7852021-03-31
Millennium Management LLC0.483%-3.275%196,144-6,6412021-06-30
Candriam Luxembourg S.C.A.0.398%0.000%161,624161,6242021-06-30
Millennium Management LLC0.358%-25.805%145,529-50,6152021-09-30
Monashee Investment Management LLC0.308%0.000%125,000125,0002021-03-31
PURA VIDA INVESTMENTS, LLC0.254%0.000%103,026103,0262021-03-31
Affinity Asset Advisors, LLC0.246%25.000%100,00020,0002021-09-30
PURA VIDA INVESTMENTS, LLC0.200%-21.257%81,126-21,9002021-06-30
Affinity Asset Advisors, LLC0.197%220.000%80,00055,0002021-06-30
Woodline Partners LP0.191%-67.597%77,386-161,4362021-06-30
Monashee Investment Management LLC0.159%-48.242%64,697-60,3032021-06-30
Citadel Advisors Llc0.145%0.000%56,55756,5572021-12-31
Macquarie Group Ltd0.136%0.000%55,24755,2472021-03-31
CAAS CAPITAL MANAGEMENT LP0.123%0.000%50,00050,0002021-03-31
JPMorgan Chase & Co0.122%-92.105%49,405-576,3452021-06-30
Macquarie Group Ltd0.100%-26.870%40,402-14,8452021-06-30
Citadel Advisors Llc0.097%0.000%39,25339,2532021-03-31
Bank of America Corp0.080%-94.385%32,346-543,7392021-06-30
Alyeska Investment Group, L.P.0.076%0.000%30,73002021-09-30
Sender Co & Partners, Inc.0.071%0.000%27,69027,6902021-12-31
Millennium Management LLC0.068%-81.844%26,423-119,1062021-12-31
Renaissance Technologies Corp0.066%0.000%25,53325,5332021-12-31
Legal & General Group PLC0.064%0.000%24,75524,7552021-12-31
BlackRock Inc0.062%0.000%25,00002021-06-30
Geode Capital Management, LLC0.045%0.000%17,59102021-12-31
Geode Capital Management, LLC0.043%0.000%17,59117,5912021-09-30
Goldman Sachs Group Inc0.033%0.000%13,00013,0002021-12-31
RTW INVESTMENTS, LLC0.031%0.000%12,22912,2292021-12-31
Jump Financial, LLC0.028%0.000%11,00011,0002021-12-31
Morgan Stanley - Brokerage Accounts0.016%0.000%6,3496,3492021-12-31
Bank of America Corp0.006%-92.682%2,367-29,9792021-09-30
Cubist Systematic Strategies, LLC0.005%0.000%1,8851,8852021-09-30
Royal Bank of Canada0.003%0.000%1,00002021-09-30
UBS Group AG0.001%0.000%4644642021-06-30
Rockefeller Capital Management L.P.0.001%0.000%25002021-09-30
S.A.C. Capital Advisors (Hong Kong) Ltd.0.000%0.000%98982021-09-30
Monashee Investment Management LLC0.000%-100.000%0-64,6972021-09-30

Mutual Fund Ownership

Worldwide Healthcare Ord is the biggest individual fund holder of Achilles Therapeutics plc (ACHL), owning a total of 1.4 million shares. Combined, the top 110 mutual fund holders of ACHL own 61.63% of the company with a total of 24.8 million shares.

In the latest ownership report, the top 110 mutual funds have increased their combined ownership of ACHL by 1.2 million shares, a 4.63% increase from the quarter prior.

Mutual Funds Chart

Your browser does not support this chart.

Top Mutual Funds

OwnerPercent OwnedPercent ChangeShares OwnedShare ChangeDate Reported
Worldwide Healthcare Ord3.607%0.000%1,406,11002021-11-30
Worldwide Healthcare Ord3.607%0.000%1,406,11002021-12-31
Worldwide Healthcare Ord3.607%0.000%1,406,11002022-01-31
Worldwide Healthcare Ord3.463%0.000%1,406,11002021-04-30
Worldwide Healthcare Ord3.463%0.000%1,406,11002021-05-31
Worldwide Healthcare Ord3.463%0.000%1,406,11002021-06-30
Worldwide Healthcare Ord3.463%0.000%1,406,11002021-07-31
Worldwide Healthcare Ord3.463%0.000%1,406,11002021-08-31
Worldwide Healthcare Ord3.463%0.000%1,406,11002021-09-30
Worldwide Healthcare Ord3.463%0.000%1,406,11002021-10-31
Worldwide Healthcare Ord3.462%0.000%1,406,1101,406,1102021-03-31
HBM Healthcare Investments AG Ord1.108%0.000%450,00002021-06-30
HBM Healthcare Investments AG Ord1.108%0.000%450,00002021-09-30
HBM Healthcare Investments AG Ord1.108%0.000%450,00002021-12-31
HBM Healthcare Investments AG Ord1.108%0.000%450,000450,0002021-03-31
HBM Healthcare Investments AG Ord1.104%0.000%450,00002022-03-31
LSP Life Sciences Fund N.V.0.740%0.166%300,5724972021-06-30
QIN IM GBP AXA Framlington Biotech0.698%0.000%272,10102022-01-31
QIN IM GBP AXA Framlington Biotech0.698%0.000%272,10102022-02-28
QIN IM GBP AXA Framlington Biotech0.698%0.000%272,10102022-03-31
QIN IM GBP AXA Framlington Biotech0.670%4.653%272,10112,0982021-10-31
QIN IM GBP AXA Framlington Biotech0.670%0.000%272,10102021-11-30
QIN IM GBP AXA Framlington Biotech0.670%0.000%272,10102021-12-31
QIN IM GBP AXA Framlington Biotech0.640%0.000%260,00302021-06-30
QIN IM GBP AXA Framlington Biotech0.640%0.000%260,00302021-07-31
QIN IM GBP AXA Framlington Biotech0.640%0.000%260,00302021-08-31
QIN IM GBP AXA Framlington Biotech0.640%0.000%260,00302021-09-30
QIN IM GBP AXA Framlington Biotech0.640%0.000%260,00302021-05-31
iShares Biotechnology ETF0.638%0.000%248,83002022-03-31
iShares Biotechnology ETF0.620%-0.155%241,686-3762022-04-28
iShares Biotechnology ETF0.619%-0.156%241,310-3762022-04-29
Wells Fargo Small Company Gr0.529%-3.820%214,873-8,5352021-05-31
Wells Fargo Small Company Growth Admin0.518%-3.877%210,308-8,4822021-05-31
iShares Biotechnology ETF0.494%-0.311%192,424-6002022-02-28
iShares Biotechnology ETF0.492%-0.225%199,924-4502022-01-31
iShares Biotechnology ETF0.485%-0.906%196,924-1,8002021-12-29
iShares Biotechnology ETF0.481%-0.534%195,424-1,0502021-12-31
Wells Fargo Small Company Gr0.385%-27.311%156,189-58,6842021-06-30
Peregrine Capital Mgt Sm-Cap Growth0.385%-30.088%156,189-67,2192021-06-30
Wells Fargo Small Company Growth Admin0.376%-27.343%152,803-57,5042021-06-30
Belfius Equities Cure C Cap0.368%0.000%149,57102021-07-31
Belfius Equities Cure C Cap0.368%0.000%149,57102021-08-31
Belfius Equities Cure C Cap0.368%0.000%149,57102021-06-30
Arctic Aurora LifeScience I USD0.185%0.000%75,00002021-05-31
Arctic Aurora LifeScience I USD0.171%-7.692%69,231-5,7692021-06-30
Arctic Aurora LifeScience I USD0.171%0.000%69,23102021-07-31
Optimum Small-Mid Cap Growth Instl0.136%0.000%55,24702021-05-31
A4Investments SICAV SIF ACCI IlanaA2EURH0.128%17.678%50,0007,5112022-04-30
A4Investments SICAV SIF ACCI IlanaA2EURH0.109%0.000%42,48942,4892022-03-31
Optimum Small-Mid Cap Growth Instl0.100%-26.870%40,402-14,8452021-06-30
Arctic Aurora LifeScience I USD0.074%-56.700%29,977-39,2542021-08-31
Fidelity® NASDAQ Composite Index®0.055%22.733%21,5903,9992022-03-31
Peregrine SC Growth CIT Founder's0.055%0.000%22,17902021-05-31
iShares Nasdaq US Biotech ETF USD Acc0.046%0.000%17,82702022-03-31
iShares Nasdaq US Biotech ETF USD Acc0.046%0.000%17,82802022-04-28
iShares Nasdaq US Biotech ETF USD Acc0.046%0.000%17,82802022-04-29
Fidelity® NASDAQ Composite Index®0.045%0.000%17,59102022-01-31
Fidelity® NASDAQ Composite Index®0.045%0.000%17,59102022-02-28
iShares Nasdaq US Biotech ETF USD Acc0.044%0.000%17,27702022-02-28
Fidelity® NASDAQ Composite Index®0.043%276.762%17,59112,9222021-09-30
Fidelity® NASDAQ Composite Index®0.043%0.000%17,59102021-10-31
Fidelity® NASDAQ Composite Index®0.043%0.000%17,59102021-11-30
Fidelity® NASDAQ Composite Index®0.043%0.000%17,59102021-12-31
iShares Nasdaq US Biotech ETF USD Acc0.043%0.000%17,38802022-01-31
iShares Nasdaq US Biotech ETF USD Acc0.042%0.000%17,00802021-12-29
iShares Nasdaq US Biotech ETF USD Acc0.042%0.000%17,00802021-12-31
Great-West Small Cap Growth Instl0.042%0.000%16,90316,9032021-03-31
Peregrine SC Growth CIT Founder's0.040%-26.868%16,220-5,9592021-06-30
Great-West Small Cap Growth Instl0.030%-26.871%12,361-4,5422021-06-30
AXA IM Wave Framlington Biotech A0.026%7.397%10,7017372021-09-30
AXA IM Wave Biotech A0.026%-3.213%10,302-3422022-01-31
AXA IM Wave Biotech A0.026%4.486%10,6444572021-12-31
AXA IM Wave Framlington Biotech A0.026%-3.215%10,357-3442021-10-31
AXA IM Wave Biotech A0.025%-1.641%10,187-1702021-11-30
AXA IM Wave Framlington Biotech A0.025%-1.641%10,187-1702021-11-30
AXA IM Wave Framlington Biotech A0.025%2.902%9,9642812021-08-31
AXA IM Wave Framlington Biotech A0.024%6.034%9,6835512021-07-31
Peregrine Capital Mgt Sm-Cap Growth0.024%-93.843%9,617-146,5722021-07-31
Wells Fargo Small Company Gr0.024%-93.843%9,617-146,5722021-07-31
Wells Fargo Small Company Growth Admin0.023%-93.852%9,394-143,4092021-07-31
AXA IM Wave Framlington Biotech A0.023%3.233%9,1322862021-06-30
AXA IM Wave Framlington Biotech A0.022%-1.711%8,846-1542021-05-31
L&G Future World ESG UK Index L £ Acc0.018%0.000%6,90502022-01-31
L&G Future World ESG UK Index L £ Acc0.018%0.000%6,90502022-02-28
L&G Future World ESG UK Index L £ Acc0.018%0.000%6,90502022-03-31
L&G Future World ESG UK Index L £ Acc0.017%0.000%6,9056,9052021-11-30
L&G Future World ESG UK Index L £ Acc0.017%0.000%6,90502021-12-31
ProShares Ultra Nasdaq Biotechnology0.014%0.000%5,4915,4912021-12-31
Fidelity® NASDAQ Composite Index®0.012%0.000%4,66902021-05-31
Fidelity® NASDAQ Composite Index®0.012%0.000%4,66902021-06-30
Fidelity® NASDAQ Composite Index®0.012%0.000%4,66902021-07-31
Fidelity® NASDAQ Composite Index®0.012%0.000%4,66902021-08-31
ProShares Ultra Nasdaq Biotechnology0.011%-19.159%4,439-1,0522022-01-31
ProShares Ultra Nasdaq Biotechnology0.010%-9.011%4,039-4002022-02-28
ProShares Ultra Nasdaq Biotechnology0.010%-0.099%4,035-42022-03-31
ProShares Ultra Nasdaq Biotechnology0.010%-0.942%3,997-382022-04-30
Optimum Small-Mid Cap Growth Instl0.006%-93.842%2,488-37,9142021-07-31
AQR Diversified Arbitrage I0.003%0.000%1,2871,2872021-03-31
Peregrine SC Growth CIT Founder's0.003%-92.497%1,217-15,0032021-07-31
Invesco Nasdaq Biotechnology ETF0.003%0.000%1,04902022-02-28
Invesco Nasdaq Biotechnology ETF0.003%0.000%95802022-03-31
Invesco Nasdaq Biotechnology ETF0.003%0.000%95802022-04-28
Invesco Nasdaq Biotechnology ETF0.002%0.000%85302022-01-31
Invesco Nasdaq Biotechnology ETF0.002%-26.652%655-2382021-12-30
GF NASDAQ Bio-Tech Idx QDII RMB0.001%0.000%4064062021-12-31
Undrly L&G Retirement Income MA Fd0.000%0.000%1701702021-12-31
Undrly L&G Retirement Income MA Fd0.000%-8.235%156-142022-03-31
Candriam Glb Oncology Impact Eq SMA0.000%0.000%1202021-06-30
Candriam Glb Oncology Impact Eq SMA0.000%0.000%1202021-07-31
Candriam Glb Oncology Impact Eq SMA0.000%0.000%1202021-08-31

Discussions

Please log in or register to share your thoughts.

DivorceTiramisu

$ACHL buy and hodl friends. we may be early
but we are not wrong. very soon.

0 Like Report
SayMyName

$ACHL I blocked some bears and I liked it!

0 Like Report
gangganggang

$ACHL all’s I know is buy and hold… no expectations

0 Like Report
im_drank

$ACHL I'm friggin bored. Just give us our money already

0 Like Report